Browse > Article
http://dx.doi.org/10.5734/JGM.2018.15.1.17

Identification of HGD mutations in an alkaptonuria patient: using the Internet to seek rare diseases  

Cho, Sang-Yeun (Department of Pediatrics, Hanyang University College of Medicine)
Kim, Ja Hye (Department of Pediatrics, Hanyang University College of Medicine)
Publication Information
Journal of Genetic Medicine / v.15, no.1, 2018 , pp. 17-19 More about this Journal
Abstract
Alkaptonuria (AKU, OMIM: 203500) is a rare autosomal recessive disorder of tyrosine metabolism due to a defect of enzyme activity, homogentisate 1,2-dioxygenase (HGD). The patients with AKU initially presented with dark urine discoloration, and ochronosis and arthritis develop after third decades of life. With advances of Internet resources, web-based health seekers for rare disease are increasing. Here, we report the case of an 18-year-old boy with AKU who visited our center due to dark black urine based on self-diagnosis via web searching of this rare condition. Compound heterozygous mutations in HGD gene, IVS5+3A>C and IVS12+6T>C were identified and both of mutations were detected in his parents. Our case illustrates the utility of publicly available Internet resources for diagnosis of rare disease.
Keywords
Alkaptonuria; Homogentisate 1,2-dioxygenase; Ochronosis; Tyrosine;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Bouwman MG, Teunissen QG, Wijburg FA, Linthorst GE. 'Doctor Google' ending the diagnostic odyssey in lysosomal storage disorders: parents using internet search engines as an efficient diagnostic strategy in rare diseases. Arch Dis Child 2010;95:642-4.   DOI
2 Nam JH, Lee JH, Park KB, Lee DH. A case of alkaptonuria: the first case in Korea. Korean J Pediatr 2006;49:329-31.   DOI
3 Yoon JR, Kim Y, Yu J, Yang JH. Ochronotic arthropathy: degenerative and complex tear of black meniscus. J Korean Orthop Assoc 2014;49:389-93.   DOI
4 Milan AM, Hughes AT, Davison AS, Devine J, Usher J, Curtis S, et al. The effect of nitisinone on homogentisic acid and tyrosine: a twoyear survey of patients attending the National Alkaptonuria Centre, Liverpool. Ann Clin Biochem 2017;54:323-30.   DOI
5 Phornphutkul C, Introne WJ, Perry MB, Bernardini I, Murphey MD, Fitzpatrick DL, et al. Natural history of alkaptonuria. N Engl J Med 2002;347:2111-21.   DOI
6 Al Essa M, Al-Shamsan L, Rashed MS, Ozand PT. Alkaptonuria: case report and review of the literature. Ann Saudi Med 1998;18:442-4.   DOI
7 Anikster Y, Nyhan WL, Gahl WA. NTBC and alkaptonuria. Am J Hum Genet 1998;63:920-1.   DOI
8 Li H, Zhang K, Xu Q, Ma L, Lv X, Sun R. Two novel mutations in the homogentisate-1,2-dioxygenase gene identified in Chinese Han Child with alkaptonuria. J Pediatr Endocrinol Metab 2015;28:453-6.
9 Braconi D, Millucci L, Bernardini G, Santucci A. Oxidative stress and mechanisms of ochronosis in alkaptonuria. Free Radic Biol Med 2015;88:70-80.   DOI
10 Peker E, Yonden Z, Sogut S. From darkening urine to early diagnosis of alkaptonuria. Indian J Dermatol Venereol Leprol 2008;74:700.
11 Fernandez-Canon JM, Penalva MA. Molecular characterization of a gene encoding a homogentisate dioxygenase from Aspergillus nidulans and identification of its human and plant homologues. J Biol Chem 1995;270:21199-205.   DOI
12 Vilboux T, Kayser M, Introne W, Suwannarat P, Bernardini I, Fischer R, et al. Mutation spectrum of homogentisic acid oxidase (HGD) in alkaptonuria. Hum Mutat 2009;30:1611-9.   DOI
13 Suwannarat P, O'Brien K, Perry MB, Sebring N, Bernardini I, Kaiser- Kupfer MI, et al. Use of nitisinone in patients with alkaptonuria. Metabolism 2005;54:719-28.   DOI
14 Introne WJ, Perry MB, Troendle J, Tsilou E, Kayser MA, Suwannarat P, et al. A 3-year randomized therapeutic trial of nitisinone in alkaptonuria. Mol Genet Metab 2011;103:307-14.   DOI